By LegitScript Folks
on June 05, 2023
LegitScript’s Addiction Treatment Certification application process is rigorous so that patients and their families can have confidence that certified providers have been thoroughly vetted. Because of its thorough nature, prospective applicants often ask what the process entails. To help prepare you, we’ve compiled these step-by-step instructions so that you’ll have everything you need when you’re ready to apply.
By Claire Guzior
on May 26, 2023
The FDA approved the drug semaglutide for those suffering from obesity, diabetes, and other weight-related illnesses. Since its approval, semaglutide has faced worldwide popularity — resulting in supply shortages.
By Thea Le Fevre
on May 17, 2023
The US Food and Drug Administration (FDA) recently warned the public about online sales of Apetamin — an unapproved drug produced internationally and sold worldwide. Read more to understand why this drug is potentially harmful to consumers.
on May 11, 2023
LegitScript vets CBD manufacturer's products for accurate and transparent labeling in line with regulatory bodies like the US Food and Drug Administration (FDA). Read further to understand what LegitScript’s CBD Certification does to protect consumers.
on May 04, 2023
LegitScript’s Associate General Counsel, Gerard Olson, dives deep into the regulatory landscape of vaping and tobacco in our Deep Dive Webinar Series. Read this recap of the webinar to understand who regulates tobacco and vaping products, and what it takes to get a tobacco product to market. Then, watch the full webinar at the button below.